Phase 3 Pediatric FH
Research payments
$193,496
Through program year 2021, $193,496 in research payments was reported against Phase 3 Pediatric FH, across 52 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $2,590 | 2 |
| 2020 | Research | $26,133 | 19 |
| 2019 | Research | $164,773 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Joseph Mahgerefteh Bronx, NY Named on 6 payments
- Vivekanand Allada Pittsburgh, PA Named on 6 payments
- Michael Tansey Iowa City, IA Named on 5 payments
- Lee Pyles Minneapolis, MN Named on 4 payments
- Emily Germain-Lee Farmington, CT Named on 4 payments
- Traci Turner Cincinnati, OH Named on 3 payments
- Frances Zappalla Wilmington, DE Named on 2 payments
- Julia Steinberger Minneapolis, MN Named on 2 payments
- Adam Ware Salt Lake City, UT Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.